| Scorecard |
|---|
|
---
|
|
Lipper
---
|
|
Zacks Investment Research
---
|
|
Standard & Poor's
---
|
|
TheStreet.com
---
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 27.9 | 3.15 | 24.75 |
| Stocks | 0.0 | 0.0 | 0.0 |
| Bonds | 68.29 | 0.0 | 68.29 |
| Other | 0.64 | 0.0 | 0.64 |
| Foreign Bonds | 23.34 | 17.03 | 6.32 |
| Foreign Stocks | 0.0 | 0.0 | 0.0 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| % Net Assets | |
|---|---|
| Glaxosmithkline Cap 0.7% | 1.69 |
| Payb Payfix 0.507 1.14.16 | 1.62 |
| Recv Payfix 0.507 1.14.16 | 1.62 |
| Payb Flt Usd 1ml 12/15/14 | 1.41 |
| Payb Payfix .69% 1.23.15 | 1.36 |
| Ge Cap Ccmt 2012-4 FRN | 1.36 |
| Payb Payfix 0.54% 3.15.16 | 1.35 |
| Recv Flt Usd 1ml 12/15/14 | 1.35 |
| Recv Payfix .69% 1.23.15 | 1.35 |
| Recv Payfix 0.54% 3.15.16 | 1.35 |
Bond Ratings (%)
Updated 03.31.2013
| Sector | |
|---|---|
| AAA | 31.07 |
| AA | 14.71 |
| A | 33.79 |
| BBB | 10.71 |
| BB | 4.33 |
| B | 3.93 |
| Below B | 1.55 |
| Other | -0.09 |
